No, not too much to ask. Could you communicate what company it is you work for? It would be interesting to know since it seems you are not the only one from your company this happened to. I am on the inside w/ Savient in another geography and wouldlike to see more quality people get the opportunity to talk directly w/ a manager. I think one of the issues is that the NE RBD is not yet officially on board, but should be soon.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an alternative browser.
You should upgrade or use an alternative browser.
-
Make it like cafepharma, but for different industries. Learn more about CompanyUnderground
No, not too much to ask. Could you communicate what company it is you work for? It would be interesting to know since it seems you are not the only one from your company this happened to. I am on the inside w/ Savient in another geography and wouldlike to see more quality people get the opportunity to talk directly w/ a manager. I think one of the issues is that the NE RBD is not yet officially on board, but should be soon.
Anonymous
Guest
Anonymous
Guest
Bottom line is that this company is ran like a 3 card monte set up in a back alley. They have NO clue, nor did they hire many people who do, what they are doing. Good luck selling this 3 legged dog
FYI. NE RBD is from Biogen Idec RA
FYI. NE RBD is from Biogen Idec RA
Anonymous
Guest
Anonymous
Guest
One thing that shines through is that there is 1 or 2 people with a major issue with Savient on this site. It reeks of contempt. This person also comes through as arrogant and high on thier horse.
Not a person this company wants on board, so it seems reasonable that is why they have not been called back. Who wants to work with a jerk like this.......eat some humble pie, will you.
In all this, not a mention of patients. A little research will show the advanced stage these patients are in, the disability, lower QOL and at high risk for CV events. Krystexxa really works well in these patients..why else a 14-1 advisory panel vote to approve?
You can continue to spew your vitrol, but no matter, you are and will be on the outside looking in. That seems to suit you and and sure suits Savient fine as well...so its a win/win.
Not a person this company wants on board, so it seems reasonable that is why they have not been called back. Who wants to work with a jerk like this.......eat some humble pie, will you.
In all this, not a mention of patients. A little research will show the advanced stage these patients are in, the disability, lower QOL and at high risk for CV events. Krystexxa really works well in these patients..why else a 14-1 advisory panel vote to approve?
You can continue to spew your vitrol, but no matter, you are and will be on the outside looking in. That seems to suit you and and sure suits Savient fine as well...so its a win/win.
Anonymous
Guest
Anonymous
Guest
No, not too much to ask. Could you communicate what company it is you work for? It would be interesting to know since it seems you are not the only one from your company this happened to. I am on the inside w/ Savient in another geography and wouldlike to see more quality people get the opportunity to talk directly w/ a manager. I think one of the issues is that the NE RBD is not yet officially on board, but should be soon.
FYI, many of the more qualified reps did not ever get a chance to speak with a manager from Savient. There is 1 poster on here who is a mental midget ass clown who thinks that this is intentional and must mean that Savient did not qualify us, that is incorrect and is pure bullshit.
We work for some of the best progressive, innovative Rheumatology specialty companies in the world, and have relationships with the infusion and hospital departments unlike no other. Leaders never forwarded on our resumes, this was recently verified.
I am in the West. My co workers who also applied actually have stronger experience 10+ yrs buy and bill, 10+Rhu are in the Mid west and never even got a phone call for an interview. Clearly something is fubar with the communication and the actual RBD's seeing the right resume or not even getting them. OR they are getting so many and they are not a highly trained or focused group of RBD's and do not understand the indicators in a reps background that translates to success for a product like this (from what I was told by someone very close to the hiring situation, this is a problem that was discussed last week).......it is no doubt either one of these or combined they are in play here.
We thought Savient was trying to build the best of the best, quite frankly the reps I know who have been interviewed were sub par and this is an unbiased view and documented, this is a small world. I am content in my current role, was not looking to jump from the frying pan into the fryer, but Leaders called a few of us top performers to see our opinion and interest level for a proposed gout launch a few months ago, were told the same thing across the board "you're background is a solid fit and to expect a face to face as soon as the RBD's scan the resume and set up interviews"....None of us were moved forward, but lets be honest, if you look at the reps who were, and I know who they are in my geography, they were the reps who were unemployed and were a "lower risk" for Savient to partner with for a temporary risky venture like the Krystexxa launch.
Do your homework, for those of you with industry specific exp. in this theater, the writing is on the wall and should not be hard to undercover by speaking with your local thought leading Rheum's and hospitalist's. This will be a non covered product and will have boulders as obstacles in every open door.
Many of us have brought similar products on formularies and have sold in similar markets or in some cases identical markets with like products. There is a reason people who matched up to closely and knew the ropes were passed over by the RBD's. That is all I am saying, this came straight from a friend who was intervening for a RBD role in the Mid West back in December and decided to not leave her current job as an RBD at a biological outfit. Believe what you want, but this is the truth. Move on, you will be glad you did not invest anything more into this..........trust me. Just trying to offer a view point from someone and other people who have been involved in this and shadow a lot of the pp thoughts on the frustration and ineptness of the process. Whenever you see the best of the best being passed over with no transparent explanation or at least courtesy communication, the hidden agenda is often revealed. Eventually it will all come out. You cheerleaders, or "the cheerleader" who comes on here with their pumping of this company and product needs to take a good look at reality before they consume the entire jug of Savient Kool Aid!!!! These are the views of many, not a few.
Anonymous
Guest
Anonymous
Guest
One thing that shines through is that there is 1 or 2 people with a major issue with Savient on this site. It reeks of contempt. This person also comes through as arrogant and high on thier horse.
Not a person this company wants on board, so it seems reasonable that is why they have not been called back. Who wants to work with a jerk like this.......eat some humble pie, will you.
In all this, not a mention of patients. A little research will show the advanced stage these patients are in, the disability, lower QOL and at high risk for CV events. Krystexxa really works well in these patients..why else a 14-1 advisory panel vote to approve?
You can continue to spew your vitrol, but no matter, you are and will be on the outside looking in. That seems to suit you and and sure suits Savient fine as well...so its a win/win.
Because this has NOTHING to do with PATIENTS!!! WAKE UP Mr. Vitrol, is that a BID dosing??? loser. This is about the scam and fraud of Savient and the Krystexxa myth about insurance coverage, in the end the Patient is the one group that will be de-serviced and handed a bill for 30K, the best strategy Savient can employ is to play stupid and dumb to the coverage and not be transparent about cost, fulfillment, and start to finish financial burdens that will come with this product. Savient wants to keep the patient and the cost under the rug and in the dark. Have you ever worked in a buy and bill environment?? I am guessing NO NO NO...... there will be the initial sales and marketing message that Krystexxa will be covered with a letter of explanation and medical necessity, then the real truth will hit the clinicians and patients when private insurers deny this dog up and down the road......then what? You are out of a gig.....wise up.....
Anonymous
Guest
Anonymous
Guest
FYI, many of the more qualified reps did not ever get a chance to speak with a manager from Savient. There is 1 poster on here who is a mental midget ass clown who thinks that this is intentional and must mean that Savient did not qualify us, that is incorrect and is pure bullshit.
We work for some of the best progressive, innovative Rheumatology specialty companies in the world, and have relationships with the infusion and hospital departments unlike no other. Leaders never forwarded on our resumes, this was recently verified.
I am in the West. My co workers who also applied actually have stronger experience 10+ yrs buy and bill, 10+Rhu are in the Mid west and never even got a phone call for an interview. Clearly something is fubar with the communication and the actual RBD's seeing the right resume or not even getting them. OR they are getting so many and they are not a highly trained or focused group of RBD's and do not understand the indicators in a reps background that translates to success for a product like this (from what I was told by someone very close to the hiring situation, this is a problem that was discussed last week).......it is no doubt either one of these or combined they are in play here.
We thought Savient was trying to build the best of the best, quite frankly the reps I know who have been interviewed were sub par and this is an unbiased view and documented, this is a small world. I am content in my current role, was not looking to jump from the frying pan into the fryer, but Leaders called a few of us top performers to see our opinion and interest level for a proposed gout launch a few months ago, were told the same thing across the board "you're background is a solid fit and to expect a face to face as soon as the RBD's scan the resume and set up interviews"....None of us were moved forward, but lets be honest, if you look at the reps who were, and I know who they are in my geography, they were the reps who were unemployed and were a "lower risk" for Savient to partner with for a temporary risky venture like the Krystexxa launch.
Do your homework, for those of you with industry specific exp. in this theater, the writing is on the wall and should not be hard to undercover by speaking with your local thought leading Rheum's and hospitalist's. This will be a non covered product and will have boulders as obstacles in every open door.
Many of us have brought similar products on formularies and have sold in similar markets or in some cases identical markets with like products. There is a reason people who matched up to closely and knew the ropes were passed over by the RBD's. That is all I am saying, this came straight from a friend who was intervening for a RBD role in the Mid West back in December and decided to not leave her current job as an RBD at a biological outfit. Believe what you want, but this is the truth. Move on, you will be glad you did not invest anything more into this..........trust me. Just trying to offer a view point from someone and other people who have been involved in this and shadow a lot of the pp thoughts on the frustration and ineptness of the process. Whenever you see the best of the best being passed over with no transparent explanation or at least courtesy communication, the hidden agenda is often revealed. Eventually it will all come out. You cheerleaders, or "the cheerleader" who comes on here with their pumping of this company and product needs to take a good look at reality before they consume the entire jug of Savient Kool Aid!!!! These are the views of many, not a few.
So, what company are you with?
Anonymous
Guest
Anonymous
Guest
Because this has NOTHING to do with PATIENTS!!! WAKE UP Mr. Vitrol, is that a BID dosing??? loser. This is about the scam and fraud of Savient and the Krystexxa myth about insurance coverage, in the end the Patient is the one group that will be de-serviced and handed a bill for 30K, the best strategy Savient can employ is to play stupid and dumb to the coverage and not be transparent about cost, fulfillment, and start to finish financial burdens that will come with this product. Savient wants to keep the patient and the cost under the rug and in the dark. Have you ever worked in a buy and bill environment?? I am guessing NO NO NO...... there will be the initial sales and marketing message that Krystexxa will be covered with a letter of explanation and medical necessity, then the real truth will hit the clinicians and patients when private insurers deny this dog up and down the road......then what? You are out of a gig.....wise up.....
This guy is a classic douchebag. If we can get insurers to pay for Remicade 10mg/kg q4 weeks in a disease state that has many alternatives, then I don't see why Krystexxa will have issues after working out the speedbumps. Why is it that other companies can get even more expensive orphan therapies approved and paid for? These are advanced patients who are at high risk for CV events, whose quality of life are significantly diminished...We don't need a lot of them to be successful and docs I have spoken to have patients and will work to find a way to get them on drug. The outcome of this remains to be seen, despite the ramblings of "Nostro-dumbass" who thinks he is the end all / be all of buy and bill sales reps out there.
....yeah, I know....blah blah blah...spew your hateful crap some more
Yours truly,
Mr. Vitrol
Anonymous
Guest
Anonymous
Guest
This guy is a classic douchebag. If we can get insurers to pay for Remicade 10mg/kg q4 weeks in a disease state that has many alternatives, then I don't see why Krystexxa will have issues after working out the speedbumps. Why is it that other companies can get even more expensive orphan therapies approved and paid for? These are advanced patients who are at high risk for CV events, whose quality of life are significantly diminished...We don't need a lot of them to be successful and docs I have spoken to have patients and will work to find a way to get them on drug. The outcome of this remains to be seen, despite the ramblings of "Nostro-dumbass" who thinks he is the end all / be all of buy and bill sales reps out there.
....yeah, I know....blah blah blah...spew your hateful crap some more
Yours truly,
Mr. Vitrol
Hey Vitrol, so you are trying to compare Remicade to Krystexxa? Are you really that dumb? Can you say apples to oranges? Not only from a therapeutic perspective but a company perspective, no comparison at all. How do you tie these two together, is this what the RBD are trying to propagate? Wow.... no wonder.
Anonymous
Guest
Anonymous
Guest
At least the savient folks have a drug to sell. Everyone jumped shipped from BMS and Centecor to go to HGSI and now waiting on a drug that will face the same reimbursement challenges of any new buy and bill drug. All of the products eventually got reimbursed
Anonymous
Guest
Anonymous
Guest
At least the savient folks have a drug to sell. Everyone jumped shipped from BMS and Centecor to go to HGSI and now waiting on a drug that will face the same reimbursement challenges of any new buy and bill drug. All of the products eventually got reimbursed
You aint going to be around long enough to wait for the reimbursement to kick in, Savient will be long gone by then, you dont find a well to sell it without coverage the first 30 days, they will fire your ass quicker than a blink. That is for dam sure!!!
Anonymous
Guest
Anonymous
Guest
One thing that shines through is that there is 1 or 2 people with a major issue with Savient on this site. It reeks of contempt. This person also comes through as arrogant and high on thier horse.
Not a person this company wants on board, so it seems reasonable that is why they have not been called back. Who wants to work with a jerk like this.......eat some humble pie, will you.
In all this, not a mention of patients. A little research will show the advanced stage these patients are in, the disability, lower QOL and at high risk for CV events. Krystexxa really works well in these patients..why else a 14-1 advisory panel vote to approve?
You can continue to spew your vitrol, but no matter, you are and will be on the outside looking in. That seems to suit you and and sure suits Savient fine as well...so its a win/win.
You don't know shit and have no concept what "Savient wants on board". Listen you little douchey you clearly are one confused little cock goblin and do not handle rejection very well, which is strange and telling, because you are going to have every single rheumatology door slammed in your face when you waltz in with a clinical joke and umber expensive shit drug like this make shift gout serum. You are going to learn rejection very quickly. LIke every single day on this job. NO coverage, NO third party reimbursements, no nothing.
First two things the doc will ask. 1) how much does it cost. 2) is it covered. NO NO! Thanks for playing.
Anonymous
Guest
Anonymous
Guest
looks like the Biogen managers hired have brought over all their reps...this is why we didn't hear anything after our initial contacts!
Anonymous
Guest
Anonymous
Guest
You aint going to be around long enough to wait for the reimbursement to kick in, Savient will be long gone by then, you dont find a well to sell it without coverage the first 30 days, they will fire your ass quicker than a blink. That is for dam sure!!!
I concur with this, there will be tremendous pressure to sell this dog the first quarter and I have been told if you can't find a way to get those relationships you promised you had translate to Krystexxa orders without coverage, you will be gone in flash...... no thanks.
Anonymous
Guest
Anonymous
Guest
looks like the Biogen managers hired have brought over all their reps...this is why we didn't hear anything after our initial contacts!
where is the new northeast rbd from ?
Anonymous
Guest
Anonymous
Guest
I concur with this, there will be tremendous pressure to sell this dog the first quarter and I have been told if you can't find a way to get those relationships you promised you had translate to Krystexxa orders without coverage, you will be gone in flash...... no thanks.
And then who will they hire as a replacement? Truth is if the people who get hired for the launch don't make this thing go, the whole thing is done.
Anonymous
Guest
Anonymous
Guest
And then who will they hire as a replacement? Truth is if the people who get hired for the launch don't make this thing go, the whole thing is done.
There will be no replacements. This is a temporary gig, when it is rejected for numerous reasons by the medical community the sales force will be abandon in typical Savient fashion. Remember no body, including the board of Savient and high ranking Ceo's did not want to launch this in-house with its own salesforce, again for multiple reasons....this will be an easy salesforce to walk away from and abort. Watch, it will happen before you know it. There was a strong reason why the company did not want to resort to having to hire their own small band aid sales and marketing division....do your homework.
Anonymous
Guest
Anonymous
Guest
There will be no replacements. This is a temporary gig, when it is rejected for numerous reasons by the medical community the sales force will be abandon in typical Savient fashion. Remember no body, including the board of Savient and high ranking Ceo's did not want to launch this in-house with its own salesforce, again for multiple reasons....this will be an easy salesforce to walk away from and abort. Watch, it will happen before you know it. There was a strong reason why the company did not want to resort to having to hire their own small band aid sales and marketing division....do your homework.
And please remind us why you are here? Did Savient kick your ass for sitting on your desk and spending 24 hours on cafepharma site and posting garbage? Grow up man. There are many intelligent readers here, so plz get lost with your non-sense posts.
Anonymous
Guest
Anonymous
Guest
For the 2nd time, all hiring has been completed but about 5 territories. Yes, 80% came from Biogen, give or take a few %'s.
All those holding your breath waiting for the recruiter to call, have a peaceful, slow death.
I didnt even send my resume to the recruiter...biogen manager now manager at Savient contacted me (and other colleagues)
ARE YOU PITIFUL UNEMPLOYED BIMBO'S GOING TO POST IN AUGUST OF 2011 saying" Still haven't heard from recruiter yet, I talked to them in April of 2010 and they said they would call me back. I have 2 decades of Rheum sales/buy & Bill, etc..."
ITS OVER now get back to work for Pfizer
All those holding your breath waiting for the recruiter to call, have a peaceful, slow death.
I didnt even send my resume to the recruiter...biogen manager now manager at Savient contacted me (and other colleagues)
ARE YOU PITIFUL UNEMPLOYED BIMBO'S GOING TO POST IN AUGUST OF 2011 saying" Still haven't heard from recruiter yet, I talked to them in April of 2010 and they said they would call me back. I have 2 decades of Rheum sales/buy & Bill, etc..."
ITS OVER now get back to work for Pfizer
Anonymous
Guest
Anonymous
Guest
Do you all know that this company has actually been around for 30 years. I dont think they are just gonna launch a product and then disappear after 6 months. Cmon people lets get real. Thats why they are hiring us to get the referrals through, get the prior auths, get the medical necessities completed for the office and get these severe patients on therapy. That is why they are paying us VVVEEERRRYYYY Well!
Anonymous
Guest
Anonymous
Guest
Do you all know that this company has actually been around for 30 years. I dont think they are just gonna launch a product and then disappear after 6 months. Cmon people lets get real. Thats why they are hiring us to get the referrals through, get the prior auths, get the medical necessities completed for the office and get these severe patients on therapy. That is why they are paying us VVVEEERRRYYYY Well!
You sound like a moron. No way you were hired. Try doing some diligence on how this micro expansion even came about and the background of some of the RBD's hired and why the 50 reps are being brought on as an investor scheme and last ditch effort. The fact that Savient even had to hire a measly 50 reps made the board so angry that one has to question how long these rep jobs are even going to last.....I give it 6 months max, and that is if the product moves quickly, which will be impossible without the medicare contract and rebates from PI. This is one big cluster, believe what you want, but based off the post above, there are some very naive people in this mix. I heard we were hiring reps who will not ask questions, as the answers will be not what one would like to hear, especially if you have a tenured background in buy and bill and infusion Rheumatology. The proceed with caution thread is spot on. Educate yourself and read the thread. Gout live in Primary care offices, the company has already stated that, 80% is their target number in PC, 50 reps covering 3 states per rep will make for one very wild goose chase...impossible territory management. There will be so much rejection due to cost, no reimbursement and private medical necessity request from the big 3 payers that reps will be constantly bagging their heads against the wall until they are either fired or quit. YOU will be spending so much time trying to assist with medical nec. letters and paperwork regarding the need and utility for the drug, that by the time your doc gets the denial letter of coverage, you best be moving on 4 hours away from that doc and staring all over again. Insanity will prevail.